Anavex Life Sciences Aktie
WKN DE: A1411S / ISIN: US0327973006
13.05.2025 13:38:33
|
Anavex Life Sciences Corp. Q2 Loss Beats Estimates
(RTTNews) - Anavex Life Sciences Corp. (AVXL) released Loss for second quarter that beat the Street estimates.
The company's earnings came in at -$11.20 million, or -$0.13 per share. This compares with -$10.55 million, or -$0.13 per share, last year.
Analysts on average had expected the company to earn -$0.15 per share. Analysts' estimates typically exclude special items.
Anavex Life Sciences Corp. earnings at a glance (GAAP) :
-Earnings: -$11.20 Mln. vs. -$10.55 Mln. last year. -EPS: -$0.13 vs. -$0.13 last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Anavex Life Sciences Corpmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Anavex Life Sciences Corpmehr Analysen
Aktien in diesem Artikel
Anavex Life Sciences Corp | 9,72 | 0,75% |
|